Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

Showing 20 of 0 results

Not applicableUnknownNCT04021888
What this trial is testing

The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAerobic ExerciseBreathing Exercise+1 more
Dokuz Eylul University 60
Testing effectiveness (Phase 2)Study completedNCT01504854
What this trial is testing

Resveratrol for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Alzheimer's Disease Cooperative Study (ADCS) 119
Testing effectiveness (Phase 2)Study completedNCT03493282
What this trial is testing

Effect of CT1812 Treatment on Brain Synaptic Density

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 43
Testing effectiveness (Phase 2)Study completedNCT06694597
What this trial is testing

Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Fujian Medical University Union Hospital 76
Post-approval studies (Phase 4)UnknownNCT05383183
What this trial is testing

Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Daewoong Bio Inc. 630
Large-scale testing (Phase 3)Study completedNCT01614886
What this trial is testing

Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 216
Large-scale testing (Phase 3)Ended earlyNCT00490568
What this trial is testing

Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,461
Testing effectiveness (Phase 2)Ended earlyNCT06185543
What this trial is testing

A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
NeuroSense Therapeutics Ltd. 8
Early research (Phase 1)Study completedNCT03822208
What this trial is testing

First in Human Study for Safety and Tolerability of AL003.

Who this might be right for
HealthyAlzheimer Disease
Alector Inc. 54
Early research (Phase 1)Study completedNCT01397539
What this trial is testing

Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 53
Early research (Phase 1)Study completedNCT04685265
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease

Who this might be right for
Parkinson Disease
MODAG GmbH 70
Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Testing effectiveness (Phase 2)Study completedNCT01137526
What this trial is testing

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 267
Large-scale testing (Phase 3)Study completedNCT00423085
What this trial is testing

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 859
Testing effectiveness (Phase 2)Study completedNCT01782742
What this trial is testing

Bexarotene Amyloid Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 20
Testing effectiveness (Phase 2)Ended earlyNCT01560585
What this trial is testing

Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University Hospitals Cleveland Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT00329082
What this trial is testing

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 25
Post-approval studies (Phase 4)Looking for participantsNCT07633470
What this trial is testing

Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Who this might be right for
Alzheimer Disease
Alpha Cognition, Inc 150
Not applicableStudy completedNCT07548073
What this trial is testing

Effect of Scene-Based Training on Cognitive Function in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment
Zhejiang Provincial Tongde Hospital 126
Not applicableStudy completedNCT00467766
What this trial is testing

Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCaregivers
Pfizer 300
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation